Oxford Biomedica (OXB), a global quality and innovation-led cell and gene therapy CDMO, today announced interim results for the six months ended 30 June 2026. Revenue growth: constant currency revenue
Oxford Biomedica is now on M&A Alert
It has thus far refused four £9 offers from Swedish investment firm EQT, which is said to be looking at Oxford BioMedica plc (LON: OXB) again now that shares are
Share Talk Weekly Stock Market News Review, Sunday 9th August 2026
The FTSE 100 closed higher on Friday, rounding off a positive week for London equities as unexpectedly weak US employment data reduced expectations for further Federal Reserve interest rate increases.
Oxford Biomedica revenues rise as new client wins hit record
Oxford Biomedica (LON: OXB) has lowered its full-year 2026 revenue and profitability guidance after changes in customer ordering patterns and delays at its US facility, despite reporting record new client activity
RNS Hotlist with Zak Mir: GDWN, AXL, TLM, OXB, GELN & AMRQ
The Telegraph: The Cambridge diversity scramble that led to Arday fiasco: University accused of ‘going through the motions’ when it appointed its youngest black professor
RNS Hotlist with Zak Mir: TAP, HVO, EST, AGR, ONDO, HERC, EDX, CPX, FME, KMK, OMI, THR, INSG, HEX, CTL, OBX, EEE & ALK
Tap Global Group (AQSE: TAP), the FinTech app bridging the gap between traditional finance and blockchain technology, announces it has raised gross proceeds of £1 million at a price of 2
RNS Hotlist with Zak Mir: COPL, SLE, BLOE, PREM, ADV, OXB, RKH, DOTD & MHC via Vox Markets
It will be interesting to see whether the stock market finally catches up with what Canadian Overseas Petroleum (COPL), an international oil and gas exploration company, has achieved over the
Share Talk Weekly Small Cap Movers & Shakers, Saturday 23rd April 2022
With the uncertainty overshadowing Oilex (ASX:AIM: OEX) after the Cambay India C-77H Re-frac Update & Revised Gas Sales Contract announcement on the 14th of April 2022.
RNS Hotlist with Zak Mir: PDL, PXC, SOLG, EST, DUKE, EKH, PPC, CMET, OXB, POG, KEFI, MSMN, CSFS, BHL, NGHT, POLX, HUR, DNL, ITX & UKOG via Vox Markets
Petra Diamonds (PDL) announced an unaudited trading update for the three months ended 31 March 2022 and the nine months to 31 March 2022.
Oxford Biomedica PLC (AIM:OXB) enter into an $842.5 Million Exclusive Worldwide Licence Agreement
OXB and Axovant Sciences Licence Agreement